Montelukast Prescribing at PARK VIEW SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
332
Total Quantity
10.1K
NHS Cost
£498
vs National Avg
-51.5%
PARK VIEW SURGERY prescribed 332 items of Montelukast over the last 12 months at a cost of £498 to the NHS. This is 51.5% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
36
Jun 2026
30
Jun 2026
25
Jun 2026
30
Jun 2026
29
Jun 2026
28
Jun 2026
23
Jun 2026
27
Jun 2026
33
Jun 2026
23
Jun 2026
23
Jun 2026
25
Prescribing Details
| Total Items | 332 |
|---|---|
| Total Quantity | 10,080 |
| Total NHS Cost | £498 |
| Presentations | 3 different forms |
| vs National Average | -51.5% |
Montelukast Prescribing Comparison
| This practice | 332 items |
|---|---|
| National average per practice | 685 items |
| Difference | -51.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.